// App-Quantinova.ai

: Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Researchers

Presenter

  • Ali Eshaghpour

Principal Investigators

  • Rachel Foote

  • Anna Phillips

  • Shreyas Sreeraman

  • Allen Li

  • Mark Crowther

Medical Centers

  • University of Ottawa/The Ottawa Hospital, Ottawa, Canada

  • McMaster University, Hamilton, Canada

  • Department of Medicine, McMaster University, Hamilton, Canada

  • Faculty of Health Sciences, McMaster University, Hamiton, Canada

  • UNIVERSITY OF WESTERN ONTARIO, London, Canada

  • Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Nephrology

Disease

  • Non-dialysis-dependent chronic kidney disease

  • Myocardial infarction

  • Renal disease

  • Anemia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Erythropoietin

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved